KR20110090217A - Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method - Google Patents
Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method Download PDFInfo
- Publication number
- KR20110090217A KR20110090217A KR1020100009876A KR20100009876A KR20110090217A KR 20110090217 A KR20110090217 A KR 20110090217A KR 1020100009876 A KR1020100009876 A KR 1020100009876A KR 20100009876 A KR20100009876 A KR 20100009876A KR 20110090217 A KR20110090217 A KR 20110090217A
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- fermentation broth
- weight
- ginseng
- broth
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 119
- 230000004151 fermentation Effects 0.000 title claims abstract description 119
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 230000036541 health Effects 0.000 title claims abstract description 18
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 9
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 7
- 235000013305 food Nutrition 0.000 title description 7
- 230000006872 improvement Effects 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title 1
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 241000242583 Scyphozoa Species 0.000 claims abstract description 18
- 244000294611 Punica granatum Species 0.000 claims abstract description 17
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 17
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 16
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 16
- 235000013376 functional food Nutrition 0.000 claims abstract description 16
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 14
- 241000132536 Cirsium Species 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 12
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 9
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 5
- 241000208340 Araliaceae Species 0.000 claims abstract 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 52
- 230000000694 effects Effects 0.000 claims description 29
- 239000004310 lactic acid Substances 0.000 claims description 26
- 235000014655 lactic acid Nutrition 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 16
- 241000931705 Cicada Species 0.000 claims description 15
- 244000163122 Curcuma domestica Species 0.000 claims description 12
- 235000003373 curcuma longa Nutrition 0.000 claims description 12
- 230000036299 sexual function Effects 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 12
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 11
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 11
- 235000013976 turmeric Nutrition 0.000 claims description 11
- 235000011201 Ginkgo Nutrition 0.000 claims description 10
- 239000010865 sewage Substances 0.000 claims description 10
- 239000002023 wood Substances 0.000 claims description 10
- 239000000052 vinegar Substances 0.000 claims description 9
- 235000021419 vinegar Nutrition 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 7
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- 244000305267 Quercus macrolepis Species 0.000 claims description 5
- 240000001439 Opuntia Species 0.000 claims description 3
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims description 3
- 241001672694 Citrus reticulata Species 0.000 claims description 2
- 239000012267 brine Substances 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 12
- 241000007126 Codonopsis pilosula Species 0.000 abstract description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract description 2
- 241000893531 Epimedium koreanum Species 0.000 abstract description 2
- 241000201320 Ligustrum japonicum Species 0.000 abstract description 2
- 244000297531 Lespedeza cuneata Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 35
- 240000004371 Panax ginseng Species 0.000 description 16
- 235000010633 broth Nutrition 0.000 description 14
- 230000001256 tonic effect Effects 0.000 description 14
- 229930182470 glycoside Natural products 0.000 description 13
- 150000002338 glycosides Chemical class 0.000 description 13
- -1 alkaloid flavonoid saponin Chemical class 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 8
- 235000017173 flavonoids Nutrition 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 150000002215 flavonoids Chemical class 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 201000001880 Sexual dysfunction Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 231100000872 sexual dysfunction Toxicity 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 239000003129 oil well Substances 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QQKAHDMMPBQDAC-CQSZACIVSA-N (6ar)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1NCC3 QQKAHDMMPBQDAC-CQSZACIVSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 241000254137 Cicadidae Species 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- QQKAHDMMPBQDAC-UHFFFAOYSA-N N-Nornuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1NCC3 QQKAHDMMPBQDAC-UHFFFAOYSA-N 0.000 description 3
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- QLTCHMYAEJEXBT-UHFFFAOYSA-N alpha-beta-D-glucopyranosyloxy-isobutyronitrile Natural products N#CC(C)(C)OC1OC(CO)C(O)C(O)C1O QLTCHMYAEJEXBT-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- QLTCHMYAEJEXBT-ZEBDFXRSSA-N linamarin Chemical compound N#CC(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QLTCHMYAEJEXBT-ZEBDFXRSSA-N 0.000 description 3
- CRTWQTRFSBJGLK-UHFFFAOYSA-N linamarin Natural products CC(C)(C#N)C1OC(CO)C(O)C(O)C1O CRTWQTRFSBJGLK-UHFFFAOYSA-N 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 2
- MIJYXULNPSFWEK-LGSDIRQTSA-N (4as,6as,6br,10r,12ar)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C[C@@H](O)C(C)(C)C2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)CC5C4=CCC3[C@]21C MIJYXULNPSFWEK-LGSDIRQTSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- FMIMFCRXYXVFTA-UHFFFAOYSA-N 3-Oxo-12-oleanen-28-oic acid Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C FMIMFCRXYXVFTA-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 229920002567 Chondroitin Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000003653 coastal water Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- VVEKCQAFOLKNKB-UHFFFAOYSA-N emodine Natural products C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O VVEKCQAFOLKNKB-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- MUMCCPUVOAUBAN-UHFFFAOYSA-N liriodenine Chemical compound C1=NC(C(=O)C=2C3=CC=CC=2)=C2C3=C(OCO3)C3=CC2=C1 MUMCCPUVOAUBAN-UHFFFAOYSA-N 0.000 description 2
- FVRABHGHBLRNNR-UHFFFAOYSA-N liriodenine Natural products O=C1C=CC=c2c1cc3nccc4cc5OCOc5c2c34 FVRABHGHBLRNNR-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 231100000544 menstrual irregularity Toxicity 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- MXEMKMNFLXVQBW-UHFFFAOYSA-N oleanoic acid Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MXEMKMNFLXVQBW-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- GWTUHAXUUFROTF-UHFFFAOYSA-N pseudochlorogenic acid Natural products C1C(O)C(O)C(O)CC1(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 GWTUHAXUUFROTF-UHFFFAOYSA-N 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 235000021013 raspberries Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- CMJGAYUQSLJSCR-WACFDSSMSA-N (-)-Hibalactone Natural products C1=C2OCOC2=CC(/C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-WACFDSSMSA-N 0.000 description 1
- VZTUKBKUWSHDFM-CYBMUJFWSA-N (-)-annonaine Chemical compound C1C2=CC=CC=C2C2=C(OCO3)C3=CC3=C2[C@@H]1NCC3 VZTUKBKUWSHDFM-CYBMUJFWSA-N 0.000 description 1
- SBZWTSHAFILOTE-SOUVJXGZSA-N (2R,3S,4S)-leucocyanidin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3[C@H](O)[C@@H]2O)=CC=C(O)C(O)=C1 SBZWTSHAFILOTE-SOUVJXGZSA-N 0.000 description 1
- ZEACOKJOQLAYTD-SOUVJXGZSA-N (2R,3S,4S)-leucodelphinidin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3[C@H](O)[C@@H]2O)=CC(O)=C(O)C(O)=C1 ZEACOKJOQLAYTD-SOUVJXGZSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- QQKAHDMMPBQDAC-AWEZNQCLSA-N (6as)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@H]1NCC3 QQKAHDMMPBQDAC-AWEZNQCLSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- BRYYLWHNGJJMQM-UHFFFAOYSA-N Anonaine Natural products C1OC2=CC3=CCNC4=C3C(=C2O1)C5=CC=CCC5C4 BRYYLWHNGJJMQM-UHFFFAOYSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- ZBKFZIUKXTWQTP-QGZVFWFLSA-N Armepavine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-QGZVFWFLSA-N 0.000 description 1
- ZBKFZIUKXTWQTP-KRWDZBQOSA-N Armepavine Natural products C([C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-KRWDZBQOSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000119012 Bequaertiodendron magalismontanum Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241000729173 Cirsium japonicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- CMJGAYUQSLJSCR-UUASQNMZSA-N Isohabilactone Natural products C1=C2OCOC2=CC(/C=C2/C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UUASQNMZSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- ZEACOKJOQLAYTD-UHFFFAOYSA-N Leucoanthocyanidin Natural products OC1C(O)C2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 ZEACOKJOQLAYTD-UHFFFAOYSA-N 0.000 description 1
- HMXJLDJMSRBOCV-UHFFFAOYSA-N Leucocyanidin Natural products OC1C(OC2C(O)C(Oc3cc(O)cc(O)c23)c4ccc(O)c(O)c4)c5c(O)cc(O)cc5OC1c6ccc(O)c(O)c6 HMXJLDJMSRBOCV-UHFFFAOYSA-N 0.000 description 1
- ZEACOKJOQLAYTD-ZNMIVQPWSA-N Leucodelphinidin Natural products O[C@H]1[C@H](c2cc(O)c(O)c(O)c2)Oc2c([C@@H]1O)c(O)cc(O)c2 ZEACOKJOQLAYTD-ZNMIVQPWSA-N 0.000 description 1
- 241000885596 Lycorma Species 0.000 description 1
- POIRVLZGTSWEMG-UHFFFAOYSA-N Magnoflorin Natural products N1CCC2=CC(OC)=C(O)C3=C2C1CC1=CC=C(OC)C(O)=C13 POIRVLZGTSWEMG-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- RFPZGZUMXXMVEL-UBSYNHCDSA-N Nelumboside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)[C@H](O)[C@H]1O RFPZGZUMXXMVEL-UBSYNHCDSA-N 0.000 description 1
- RFPZGZUMXXMVEL-UHFFFAOYSA-N Nelumboside Natural products OC1C(O)C(O)C(CO)OC1OC1C(C(O)=O)OC(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)C(O)C1O RFPZGZUMXXMVEL-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000092659 Pleuropterus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- JCTYWRARKVGOBK-CQSZACIVSA-N Remerin Chemical compound C12=C3C4=CC=CC=C4C[C@H]1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-CQSZACIVSA-N 0.000 description 1
- JCTYWRARKVGOBK-UHFFFAOYSA-N Roemerine Natural products C12=C3C4=CC=CC=C4CC1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-UHFFFAOYSA-N 0.000 description 1
- 241001618264 Rubus coreanus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102100033121 Transcription factor 21 Human genes 0.000 description 1
- 101710119687 Transcription factor 21 Proteins 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000010234 biliary secretion Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- FPUXKXIZEIDQKW-MFJLLLFKSA-N ginkgolide A Natural products O=C1[C@H](C)[C@@]2(O)[C@@H](O1)C[C@]13[C@@H]4OC(=O)[C@]21O[C@@H]1OC(=O)[C@H](O)[C@]31[C@@H](C(C)(C)C)C4 FPUXKXIZEIDQKW-MFJLLLFKSA-N 0.000 description 1
- SQOJOAFXDQDRGF-WJHVHIKBSA-N ginkgolide B Natural products O=C1[C@@H](C)[C@@]2(O)[C@@H]([C@H](O)[C@]34[C@@H]5OC(=O)[C@]23O[C@H]2OC(=O)[C@H](O)[C@@]42[C@H](C(C)(C)C)C5)O1 SQOJOAFXDQDRGF-WJHVHIKBSA-N 0.000 description 1
- FPUXKXIZEIDQKW-VKMVSBOZSA-N ginkgolide-a Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13C[C@@H]1OC(=O)[C@@H](C)[C@]21O FPUXKXIZEIDQKW-VKMVSBOZSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000011759 gum bleeding Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- SELIRUAKCBWGGE-UHFFFAOYSA-N hexadecanoic acid;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O SELIRUAKCBWGGE-UHFFFAOYSA-N 0.000 description 1
- CMJGAYUQSLJSCR-UHFFFAOYSA-N hibalactone Natural products C1=C2OCOC2=CC(C=C2C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- SBZWTSHAFILOTE-UHFFFAOYSA-N leucocianidol Natural products OC1C(O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 SBZWTSHAFILOTE-UHFFFAOYSA-N 0.000 description 1
- 229940086558 leucocyanidin Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 239000002420 orchard Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000007529 rheumatic myocarditis Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- CMJGAYUQSLJSCR-ULIPXBITSA-N savinin Chemical compound C1=C2OCOC2=CC(\C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-ULIPXBITSA-N 0.000 description 1
- JGPMLTMSOKTANE-UHFFFAOYSA-N savinin Natural products O=C1OCC(/C/1=Cc2ccc3OCOc3c2)c4ccc5OCOc5c4 JGPMLTMSOKTANE-UHFFFAOYSA-N 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은, 인간이 나이가 들어감에 따라 성기능장애가 많이 발생되는데, 이런 성기능이 저하되는 증세를 개선하고 그 기능을 회복하는 효과를 갖는 건강기능식품 조성물 및 그의 제조방법에 관한 발명이다. The present invention is a lot of sexual dysfunction occurs as a human age, the invention relates to a health functional food composition and a manufacturing method having an effect of improving the symptoms of reduced sexual function and restores its function.
본 발명 건강기능식품은 자양 강장 강정 성기능 강화에 효과가 좋은, 한약재로도 널리 알려져 있으며, 독성이 별로 없고 습관성이 없는 자연 약용식물인 삼지구엽초, 야관문, 가시오가피, 울금, 광나무, 만삼, 복분자, 하수오, 은행나무, 연, 인삼, 석류, 아마씨, 엉겅퀴, 꽃매미 등을 일반 물을 사용하지 않고, 해양생태환경을 파괴하여 국가적인 문제가 되고 있는 강장동물인 해파리의 추출액만을 이용하여 유산균으로 발효시켜 얻어진 발효액을 주원료로 하는 것이다.The health functional food of the present invention is also widely known as an herbal medicine, which is effective in enhancing the nourishing tonic jeongjeongseong, and is not toxic and habitless natural medicinal plants, trichophyte vinegar, night gate, thorny gopi, turmeric, mineral wood, ginseng, bokbunja, sewage Fermented with lactic acid bacteria using extracts of jellyfish, a tonic animal that has become a national problem by destroying marine ecological environment without using general water, ginkgo, lotus, ginseng, pomegranate, flaxseed, thistle, and cicada The obtained fermentation broth is used as a main raw material.
본 발명 조성물은, 내분비계, 혈관계, 신경계, 정신계 등의 상호작용에 의해 이루어지는 혈류역동학적의 복잡한 생리 반응과정에서의 어느 하나의 이상으로도 발생 될 수 있는, 성기능 장애를 개선하고 회복의 효과를 갖는 무수유산균발효 건강기능식품 조성물 및 그의 제조 방법에 관한 발명이다.The composition of the present invention improves sexual dysfunction and may recover from any one or more abnormalities in the hemodynamic complex physiological reaction process which is made by interactions of the endocrine, vascular, nervous, and mental systems. The present invention relates to an anhydrous lactic acid bacteria fermentation health functional food composition having and a method for producing the same.
성기능장애는 40대 39%, 50대 49%, 60대 58%, 70대 67%정도가 발생된다고 알려지고 있는데, 성인병의 증가 및 식생활 변화, 산업사회화와 복잡한 현대생활로 인한 육체적인 피로와 정신적인 스트레스가 연속됨에 따라 성기능장애 환자들이 증가하고 있다.Sexual dysfunction is reported to occur in the 40's 39%, 50's 49%, 60's 58%, 70's 67%. Physical fatigue and mentality due to the increase in adult disease, dietary changes, industrial socialization and complex modern life As human stress continues, sexual dysfunction patients are increasing.
따라서 이에 대한 다양한 종류의 성기능개선의 건강기능식품이 개발 출시되어 알려지고 있지만, 우리 주변에 많이 볼 수 있는 김치 된장 간장 요구르트 홍어 굴비 등에서와 같은 발효를, 보다 특수한 방법인 특수고압 무수 유산균발효 방법으로 응용하여, 흡수를 쉽게 하고 효과를 증진시켜주는 특수고압 무수 유산발효 건강기능식품으로 성기능 장애의 개선에 안정적이며 매우 효과적이다.
Therefore, various kinds of sexual function improvement health functional foods have been developed and released, but fermentation such as kimchi miso soy sauce yogurt skate oyster, which can be seen a lot around us as a special high pressure anhydrous lactobacillus fermentation method It is a special high-pressure anhydrous fermentation fermentation health functional food that is easy to absorb and enhances the effect.It is stable and very effective in improving sexual dysfunction.
지금까지는 성기능 개선의 건강기능식품 등은 한약재와 같이 달여서 추출하거나 술로 추출하여 이용하는 방법들이 대부분으로 알려지고 있다.Until now, health functional foods, such as improving sexual function, are known to be used to extract or decoction with alcohol, such as herbal medicine.
이러한 방법들은 식물의 방어 독성 또한 같이 섭취할 수밖에 없거나 그 식물의 성분을 제대로 이용할 수 없는 구조적 문제를 안고 있다. 식물의 고유특성인 글리코시드(Glycoside:배당체)는 가열이나 알코올에 분해되어 그 특성을 상당부분 잃게 된다. These methods have structural problems that inevitably involve the defensive toxicity of the plant or ingest the components of the plant. Glycosides (glycosides), which are inherent to plants, lose much of their properties when they are degraded by heating or alcohol.
또한, 발효방법도 발효용기를 오픈 하거나 옹기 등의 보통 용기사용으로, 정밀발효가 어려운 점이 있어 효과를 제대로 발휘하기 어려웠다.In addition, the fermentation method is also difficult to exert the effect correctly because it is difficult to precise fermentation by opening the fermentation vessel or using ordinary containers such as Onggi.
생약제제보다는 화학적인 추출이나 합성으로 얻어지는 건강기능식품은 거부반응이나 습관성 등 부작용을 일으키는 경우가 있었으며, 시판되고 있는 성기능 개선제(발기부전 치료제)들은 혈관확장 작용으로 심장에도 무리를 주는 등 심각한 부작용을 초래하기도 한다.
Health functional foods obtained by chemical extraction or synthesis rather than herbal medicines may cause side effects such as rejection and addiction, and commercially available sexual function improving agents (erectile dysfunction treatment agents) have serious side effects such as straining the heart through vasodilation. It may also result.
본 발명은 식물발효에서 식물의 고유성분을 그대로 녹여내서, 즉 완벽하게 발효시켜, 제대로 용출된 성분의 흡수를 쉽게 할 수 있도록 하며 그 효과를 증대시키는데 있다. The present invention is to dissolve the intrinsic component of the plant as it is in plant fermentation, that is to fully fermentation, to facilitate the absorption of properly eluted components and to increase the effect.
또 식물에 있는 독성을 제거하거나 중화시켜 우리에게 유익한 성분만을 이용할 수 있도록 해야 한다. We should also remove or neutralize the toxicity in our plants so that only ingredients that are beneficial to us are available.
지금까지 잘 알려져 있는 자양 강장 강정이나 성기능 개선에 효과가 있는 약용식물을 정밀 발효시켜, 여러 식물 고유특성과 성분의 발효액을 최적의 비율로 유기적인 조합을 하여 성기능 개선의 효과가 극대화 되도록 해야 한다.
The fermentation of medicinal plants that are effective to improve nourishment tonic or sexual function, which is well known, should be precisely fermented, and the organic combination of fermentation broths of various plant intrinsic characteristics and ingredients should be optimized in order to maximize the effect of improving sexual function.
본 발명에서 이용하는 비피더스(Bifidobacterium)균이나 락토바실러스(Lactobacillus)균 등 유익한 유산균은 일반적으로 20~50℃에서 활성화되며, 이 상태에서는 포도상구균 등의 유해세균이 증식할 수 없다고 알려져 있다. Advantageous lactic acid bacteria such as Bifidobacterium bacteria and Lactobacillus bacteria used in the present invention are generally activated at 20 to 50 ° C., and harmful bacteria such as staphylococci cannot be grown in this state.
지금까지 알려진 유산균의 작용은 장내 유해균 억제 작용 및 정장작용, 혈중 콜레스테롤 감소 기능, 면역 증강 작용, 내인성 감염 억제 작용, 간경화 개선 작용 항암작용 등의 역할로 우리 몸의 건강을 지켜주는 미세조정 역할을 하고 있다고 한다.The action of lactic acid bacteria known so far is to act as a fine adjustment to protect the health of our body by the role of inhibiting intestinal harmful bacteria and intestinal action, reducing blood cholesterol, enhancing immune function, inhibiting endogenous infection, improving liver cirrhosis, etc. It is said.
글리코시드(Glycoside:배당체)는 식물 특유의 성분으로, 당의 환원기와 당이나 화합물의 하이드록시기가 탈수축합하여 생긴 물질로 모든 식물에 존재하며, 당의 저장, 삼투압 조절, 해독 작용, 식물대사의 노폐물 제거 작용을 한다. Glycoside (glycoside) is a plant-specific component, a substance formed by dehydrating condensation of sugars and hydroxyl groups of sugars or compounds, present in all plants, and storing sugars, controlling osmotic pressure, detoxification, and eliminating plant metabolism. It works.
각 식물의 이 배당체가 특유의 효과를 나타내는데, 가열이나 알코올에 담가내면 배당체가 분해되어 효력이 줄어들 수밖에 없다. This glycoside of each plant has a unique effect. When heated or immersed in alcohol, the glycosides are decomposed and the effect is reduced.
본 발명은 특수고압유산발효로 배당체의 손상이 없이 그 식물의 고유특성을 그대로 이용할 수 있는 발명이다. The present invention is an invention that can use the intrinsic properties of the plant as it is without damaging the glycosides by special high pressure lactic acid fermentation.
바다의 강장동물인 해파리(Jelly fish)는 지구의 온난화로 우리나라 연근해에까지 번식하며 개체수가 기하급수적으로 늘어나 해양생태환경을 파괴하는 유해 동물로 국가적인 문제를 일으키고 있다. Jelly fish, a tonic animal of the sea, breeds in the coastal waters of Korea due to global warming, and the population grows exponentially, causing national problems as a harmful animal that destroys marine ecological environment.
이 해파리에는 콘드로이틴이라는 물질이 주성분인 미끈미끈한 뮤신(Mucin)이라는 성분을 많이 함유하고 있는데, 그 성분은 신체 조직 중 수분을 유지하는 작용이 있어 피부나 혈관 내장 등에 윤기를 주게 되며, 강장작용 노화방지 고혈압 개선의 효과가 있다.This jellyfish contains a lot of slimy mucin, the main ingredient of chondroitin, which keeps moisture in body tissues and gives luster to skin and blood vessels. It has the effect of improving hypertension.
꽃 매미는 주홍 날개 꽃 매미(중국매미라고도 함)는 2007년부터 우리나라에 본격적으로 발생하기 시작하며 가죽나무 등 나무의 수액을 빨아먹으며 나무를 고사시키고 있어 생태환경을 파괴하는 유해곤충으로 지자체들은 그 방제에 총력을 기울이고 있는 실정인데, 중국 <본초강목> <황제내경>의 의학서에 약용곤충으로 강정, 혈액순환에 좋고 해독효능이 있어, 혈류개선과 발기부전에 효과가 뛰어나다고 한다.Flower cicadas are scarlet-winged flower cicadas (also known as Chinese cicadas), which began to occur in Korea in 2007, and sucked the sap of trees such as leather trees to kill trees. The situation is to concentrate on the control, the medical book of the Chinese herbal medicine <emperor bore> is a medicinal insect as a medicinal insect, good for blood circulation and detoxification effect, it is said to be effective in improving blood flow and erectile dysfunction.
현대의 질병은 도시화 산업화로 생활환경이나 식생활이 자연환경에서 멀어지면서 발생이 증가하고 있다고 한다.Modern diseases are reported to increase as the living environment and dietary life move away from the natural environment due to the industrialization of urbanization.
자연의 일부인 유산균을 활용하고, 자연의 식물을 그대로 이용하며, 자연의 발효방법을 이용할 때 거부감이나 부작용없이 질병이 개선된다고 한다. Lactobacillus, which is part of nature, uses natural plants as it is, and uses natural fermentation methods to improve disease without rejection or side effects.
발효는 일반적으로는 보통 상압의 상태에서 진행되는데, 특수용기에 100~150기압의 특수고압발효를 진행하면 발효대상식물이 10~50나노로 완전발효되어 그 성분이 완전하게 녹아나 제대로 이용할 수 있고 흡수를 용이하게 한다.Fermentation is usually carried out under normal pressure. When special high-pressure fermentation is carried out in a special container at 100 to 150 atm, the fermented plant is completely fermented to 10 to 50 nanometers, so that its ingredients are completely dissolved and can be used properly. To facilitate absorption.
본 발명에서는 상기의 과제를 해결하기 위하여, 발효 시 일반 물을 사용하거나 상압발효를 하는 등의 일반발효를 지양하고, 특수용기에 해파리 추출액만을 사용하여 100~150기압의 특수고압 유산발효방법으로 완전발효를 하여, 그 발효액으로 성기능 개선효과를 갖는 무수유산균발효 건강기능식품 조성물 및 그의 제조방법을 제시한다.In the present invention, in order to solve the above problems, to avoid the general fermentation, such as using normal water or normal pressure fermentation at the time of fermentation, using a jellyfish extract in a special container only 100 to 150 atm of special high pressure lactic acid fermentation method The fermentation, the fermentation broth present an anhydrous lactic acid bacteria fermentation health functional food composition having a sexual function improving effect and a method for producing the same.
본 발명 건강기능식품은 항암 강장 강정 성분을 함유한 각각의 생약 식물을 해파리추출액에 유산균을 각각 발효하여 얻어진 발효액을 최적의 상태로 혼합 조성하는 것이다.The health functional food of the present invention contains an anticancer tonic component The fermentation broth obtained by fermenting the lactic acid bacteria to the jellyfish extract each of the herbal medicines is mixed composition in an optimal state.
본 발명 조성물은 자연 상태에서 식물의 특유성분이 최대로 함유한 시기인 개화기에 맞춰 채취 1~5mm로 분쇄하여, 상기 해파리에서 추출한 액에, 비피더스나 락토바실러스 유산균과 발효촉진 물질인 설탕과 올리고당을 특수고압 발효탱크에 함께 넣어 일정온도와 일정시간 발효시켜 얻어진 발효액을 적정량 혼합하여 본 발명 조성물을 얻는다. The composition of the present invention is ground to 1 ~ 5mm collected in accordance with the flowering period, which is the period of the maximum natural content of the plant's unique components, and in the liquid extracted from the jellyfish, bifidus or Lactobacillus lactic acid bacteria and sugar and oligosaccharides as fermentation promoting substances A fermentation broth obtained by putting together a special high pressure fermentation tank and fermenting at a constant temperature and for a predetermined time is mixed to obtain a composition of the present invention.
본 발명 조성물은The composition of the present invention
삼지구엽초, 야관문, 가시오가피, 울금, 광나무, 만삼, 복분자, 하수오, 은행나무, 연, 인삼, 석류, 아마씨, 엉겅퀴, 꽃매미, 해파리추출액을 주재료로 구성되며, 이들에 각각 유산균과 발효촉매제를 넣고 발효시켜 얻어진 발효액으로 이루어진다. The main components are trichophyte leaf, night view gate, thorny goose, turmeric, mineral wood, ginseng, bokbunja, sewage, ginkgo, lotus, ginseng, pomegranate, flaxseed, thistle, flower cicada, jellyfish extract, and each of them contains lactic acid bacteria and fermentation catalyst. It consists of a fermentation broth obtained by fermentation.
상기 조성물의 주원료인 약용 식물은 한의학을 비롯하여 현대 의학에서도 널리 알려진 약재들로서 특히 자양 강장 강정의 성기능개선에 효능이 있다.Medicinal plants, which are the main ingredients of the composition, are widely known in Korean medicine and modern medicine, and are particularly effective in improving sexual function of nourishing tonic gangjeong.
본 발명은 상기 식물이 갖는 효능을 최대한으로 끌어내면서도 부작용이 없이 장시간 복용할 수 있으며, 효과적인 발효를 위하여 일반적인 유산균 발효에서 이용되는 물을 사용하지 않고 해파리 추출액만을 사용하고, 주원료를 10~50나노로 완전발효용해시켜 흡수가 잘되도록 하기 위하여 100~150기압의 특수고압 발효탱크에 발효시키는 것이 본 발명이 이루고자하는 과제 해결수단이다.
The present invention can be taken for a long time without any side effects while maximizing the efficacy of the plant, and using only jellyfish extract without using water used in common lactic acid fermentation for effective fermentation, the main raw material 10 ~ 50nm The fermentation in a special high-pressure fermentation tank of 100 to 150 atm in order to completely absorb the fermentation so as to be absorbed is a problem solving means to achieve the present invention.
상기 삼지구엽초(학명 :Epimedium koreanum)는 음양곽(淫羊藿) 방장초 선령비 팔파리 등의 이름을 갖는 다년생초로, 알칼로이드 플라보노이드 사포닌이 주성분이며, 세릴알콜, 팔미틴산 스테아린산, 리놀레인산, 비타민E, 마그노플로린과 강장 강정작용에 효과가 있는 이카리인 에피메딘 데스메틸이카리인이 함유되어 있다.The trigeminal leaf vinegar (Epimedium koreanum) is a perennial herb that has a name such as Eumyanggwa (淫羊藿) Bangjangcho Seonbibi palpari, alkaloid flavonoid saponin is the main ingredient, seryl alcohol, palmitic acid stearic acid, linoleic acid, vitamin E, It contains epicardin epimethine desmethyl icarine, which is effective in magnoflorin and tonic tonic action.
<동의학사전>에서는 "신양을 보하고 정기를 도우며 힘줄과 뼈를 튼튼하게 하고 풍습을 없앤다고 알려지고 있으며 강정작용, 이뇨작용, 혈압을 낮추는 작용 등이 실험으로 밝혀지고 있는것으로 음위증, 성신경쇠약증, 성호르몬 장애등에 쓰며 소변불통, 귀울음, 건망증, 마비, 생리불순 등에 쓴다.In Dong-eok Dictionary, it is known that it protects Shin-yang, helps regularity, strengthens tendons and bones, and eliminates customs, and gangjeong, diuretic, and blood pressure-lowering effects are found in experiments. It is used for sexual hormone disorders such as urinary pain, tinnitus, forgetfulness, paralysis, and menstrual irregularities.
또한 허약한 사람의 보약으로도 이용되며 하루 6~10그램을 달여 먹는다고도 알려지고 있다.It is also used as a medicine for weak people and is known to eat 6-10 grams a month.
이와 같이 삼지구엽초는 전통적으로 보양 강정 성기능 개선에 특효 약제로 사용하였다. In this way, trichophytic vinegar has traditionally been used as an effective drug for improving the rehabilitation of sexual fertility.
상기 야관문(夜關門-학명:Lespedeza cuneata )은 비수리, 폐문초(閉門草), 음양초(陰陽草), 천리광(千里光), 대력왕(大力王)이라고도 하며, 속칭 천연비아그라라고 하기도 한다. 야관문의 잎 뿌리 줄기에 플라보노이드, 피니톨, 페놀, 탄닌, 시토스테롤 등의 성분이 있는데, 폐와 간 신장에 주로 작용한다. The night view (Le-spedeza cuneata) is also known as non-repair, closed gate, Eumyangcho, Cheonli-gwang, the Great King (大力 王), also known as natural viagra. . Flavonoids, pinitol, phenol, tannins, and cytosterol are found in the leaf rhizome of the night gate, and mainly act on lung and liver kidneys.
간과 신장을 튼튼하게 하고 어혈을 없애며 부은 것을 내리게 한다.It strengthens the liver and kidneys, removes blood, and swells.
특히 몽정, 대하, 설사, 타박상, 천식을 낫게 하고 눈을 밝게 하며 근육과 힘줄을 부드럽게 하며, 혈액순환이 잘 되게 한다. 여러 가지 남성 질병, 양기부족, 조루, 유정, 음위증 등을 치료하는 데 뛰어난 효력이 있으며 신장기능이 허약한 노인들의 양기부족에 탁월한 효과가 있다고 한다. In particular, dreams, treats, diarrhea, bruises, asthma, to soothe the eyes, soften muscles and tendons, blood circulation is good. It is effective in treating various male diseases, lack of nourishment, premature ejaculation, oil well, and vulgaris, and it is said to have an excellent effect on the lack of yang of elderly people with weak kidney function.
상기 가시오가피나무(학명:Acanthopanax senticosus) 는 우리나라 각지의 해발 400~1,800미터 되는 산기슭이나 산골짜기에서 자라는 약용나무이다. 맛은 맵고 쓰며 성질은 따듯하여 간경, 신경에 작용한다.The prickly oak tree (Acanthopanax senticosus) is a medicinal tree that grows in the foothills or valleys of 400 ~ 1,800 meters above sea level in Korea. The taste is spicy and bitter, and the nature is warm, acting on the liver and nerves.
잎, 줄기 뿌리에 정유, 플라보노이드 그리고 쿠마린 성분과 8개의 배당체 성분인 엘레우테르시드군, 다우코스테린, 시린긴, 이소프락시린과 포도당의 결합체인 이소프락신, 사린가레시놀의 포도당배당체, 시린긴 등의 성분이 있다. Essential oils, flavonoids and coumarins and the eight glycosides of the leaf and stem roots, the eleuterid group, doucosterin, syringin, isoproxine, a combination of isoproxirin and glucose, glycosides of glycerin and sarginine And other components.
또 다우코스테롤, 强心配糖體(강심배당체), 세사민, 사비닌, 사포닌, 올레아놀산을 게닌으로 하는 배당체들이 들어 있습니다. It also contains glycosides, including dowsterol, cardiac glycosides, sesamin, savinin, saponin, and oleanoic acid.
이 가시오가피는 기(氣)를 보하고 정(精)을 불려주어 간신(肝腎)을 보한다. 또한 근육과 뼈를 튼튼하게 하고 풍습(風濕)을 없앤다.This prickly go sees Qi and sends the tablets and sees Ganshin. It also strengthens muscles and bones and eliminates customs.
약리실험에서 중추신경흥분작용, 피로회복촉진작용, 면역부활작용, 방사선막이작용, 혈당량감소작용, 백혈구증식작용, 강장작용, 소염작용, 진해작용, 거담작용 등이 밝혀졌다. In pharmacological experiments, central nervous system excitement, fatigue recovery, immune revival, radiation barrier, blood glucose reduction, leukocyte proliferation, tonic, anti-inflammatory, antitussive, and expectorant action were found.
몸이 약하고 기운이 없는데, 피로, 당뇨병, 동맥경화증, 저혈압, 류머티즘성심근염, 관절염 및 류머티즘성관절염, 신경통 등에 효과가 있다고 알려져 있다. The body is weak and weak, and it is known to be effective in fatigue, diabetes, arteriosclerosis, hypotension, rheumatoid myocarditis, arthritis and rheumatoid arthritis, neuralgia.
상기 울금(학명:Curcuma longa Linne)은 강황(薑黃)이라고도 하며, 카레의 주원료이다. 열대지방인 인도차이나가 원산이고, 주산지는 인도, 스리랑카, 자바, 중국, 페루 등이며, 우리나라의 중남부지역에서도 재배된다. 강력한 항산화작용을 하는 Curcumin성분과, turmerone, arturmerone, zingiberene, PTMC 등을 함유하고 있으며, 비장(脾臟)과 간(肝)에 주로 작용한다. The turmeric (Curcuma longa Linne) is also known as turmeric (薑黃), is the main raw material of curry. It is native to the tropical region of Indochina, and its main origin is India, Sri Lanka, Java, China, and Peru. Curcumin, a powerful antioxidant, contains turmerone, arturmerone, zingiberene, and PTMC, and acts primarily on the spleen and liver.
약리작용은 위산분비 조절, 위염, 건위, 위궤양, 담즙분비 촉진, 간 해독기능 향상, 황달, 담낭결석, 간장질환, 담관염, 간염(만성간염, C형간염), 생리불순, 월경통, 자궁근종, 산후복통, 무월경, 동맥경화에 효과가 있으며, 혈행활성, 관상동맥 반괴형성 감소, 강심작용, 항산화작용-노화예방, 항염작용, 항균작용을 한다.Pharmacological actions include gastric acid secretion, gastritis, gastric ulcer, gastric ulcer, biliary secretion, liver detoxification, jaundice, gallbladder stones, liver disease, cholangitis, hepatitis (chronic hepatitis, hepatitis C), menstrual disorders, dysmenorrhea, uterine myoma, It is effective in postpartum abdominal pain, amenorrhea and arteriosclerosis. Its hematologic activity, decreased coronary artery mass formation, cardiac action, antioxidant action-anti-aging, anti-inflammatory action, antibacterial effect.
상기 광나무(학명:Ligustrum japonicum)는 물푸레나무과에 딸린 상록 떨기나무다. 정목, 또는 여정목이라고 부르며 그 열매를 여정실, 또는 여정자라고 한다. 광나무 열매는 예로부터 자음생정약으로 유명하며 꾸준히 먹으면 정기가 증강되고 무병장수한다고 한다고 알려져 있으며, 면역기능을 높이고 신장을 강화시켜 준다고 알려져 있다. Ligustrum japonicum is an evergreen evergreen tree attached to the ash family. It is called the jeongmok, or journey tree, and its fruit is called the journey room, or journeyman. The fruit of the orchard is famous for its consonant biomedical medicine since ancient times, and it is known that if eaten steadily, it improves regular and disease-free life. It is known to enhance immune function and strengthen kidney.
그 성분으로는 오레아놀산, 만니톨, 팔리틴산, 스테아린산, 올레인산, 리놀레인산, 레아놀산, 아세틸올레아놀산, 우르솔산이 들어있다. 불면증, 식욕부진, 고혈압, 신경통, 관절염, 근육통 등에 효과가 있으며, 만니톤은 남성의 정력을 높이는 효과 시링긴은 여성의 성감을 높이는 효과가 있다고 알려져 있다. Its components include oleanolic acid, mannitol, paric acid, stearic acid, oleic acid, linoleic acid, reanolic acid, acetyloleanoic acid and ursolic acid. It is effective for insomnia, anorexia, hypertension, neuralgia, arthritis, and muscle pain. Manniton is known to enhance men's virility.
상기 만삼(蔓蔘-학명:Codonopsis pilosula )은 도라지과에 속하는 다년생 덩굴식물로, 성분은 뿌리에 펙틴 9.5%, 덱스트린 3.4% 수지, 정유 0.05%, 총당분 28%, 사포닌, 스테로이드 배당체가 있으며, 이눌린이 많다. 전초에는 알칼로이드가 0.04%들어 있다. The ginseng (蔓 蔘-Scientific name: Codonopsis pilosula) is a perennial vine plant belonging to the bellflower family, the component is pectin 9.5%, dextrin 3.4% resin, essential oil 0.05%, total sugar 28%, saponin, steroid glycosides in the root, inulin There are many. The outpost contains 0.04% alkaloids.
만삼은 인삼을 대신할 수 있는 보약이라고 알려져 있다.Mansam is known as a substitute for ginseng.
또한 만삼에는 보혈작용, 강장 작용, 망상내피계통의 탐식기능강화작용, 저항성을 높이는 작용, 적혈구와 혈색소량을 늘리는 작용, 화학요법 또는 방사선치료로 줄어든 백혈구수를 늘리는 작용, 병후 쇠약, 만성위염, 빈혈, 만성소대장염, 설사, 정신피로, 식욕증진, 백혈구감소증에 효과가 있다고 알려져 있다. In addition, ginseng has the effect of blood, tonic, reinforce the phagocytosis of the reticulent endothelial system, to increase the resistance, to increase the amount of red blood cells and hemoglobin, to increase the number of white blood cells reduced by chemotherapy or radiation therapy, debilitating disease, chronic gastritis, Anemia, chronic colitis, diarrhea, mental fatigue, appetite, leukopenia is known to be effective.
상기 복분자(覆盆子-학명:Rubus coreanus)는 요강을 뒤엎는 열매라는 이름과 같이 양기에 효과가 있는 식물로 예부터 이용되어 왔다.The bokbunja (覆盆子-Scientific name: Rubus coreanus) has been used since ancient times as a plant that is effective in Yang Yang, such as the name of fruit that upsets the lumen.
이 복본자는 우리나라 산야에 흔히 자라는 나무딸기를 가리킨다. 5월에 흰 꽃이 피어 7∼8월에 검붉은 빛깔로 익는데 익은 것은 새콤달콤하여 맛이 좋다. 산딸기는 잎 열매 줄기에 플라보노이드, 뿌리에 트리테르펜사포닌, 열매에 사과산, 레몬산, 포도주산, 살리실산, 포도당, 서당, 과당, 펙틴, 점액질, 색소, 정유, 안토시안, 비타민C 등의 성분이 들어 있다. This copywriter refers to raspberries that commonly grow in the mountains of Korea. White flowers bloom in May and ripen dark red in July-August. Ripes are sour and sweet. Raspberries contain flavonoids on leaf stalks, triterpensaponins on roots, malic acid, lemon acid, vitric acid, salicylic acid, glucose, sucrose, fructose, pectin, mucus, pigments, essential oils, anthocyanins, and vitamin C.
기운을 돋우고 몸을 가볍게 하며 눈을 밝게 하고 머리털을 희어지지 않게 한다. 신장과 간장에 작용하여, 신장을 튼튼하게 하여 음위 유정 몽정을 치료하고 소변의 양과 배설 시간을 일정하게 유지하도록 도와준다고 한다. Energize, lighten your body, brighten your eyes, and avoid whitening your hair. It acts on the kidneys and liver, strengthening the kidneys, which helps to treat the umbilical wells and to maintain a constant amount of urine and excretion.
상기 하수오(학명:Pleuropterus multflorus)는 마디풀과 다년생 낙엽목질덩굴식물로 줄기가 1-3m 정도로서 비교적 짧은 편이다. 옥시메틸안트라키논 유도체들인 크리소파놀파 크리소파놀안트론, 에모딘, 에모딘모노메틸에스테르, 피스시온과 그 유도체 등이 1.8% 들어 있으며, 농마45%, 기름3%, 레시틴 3.7%, 테트라히드록시스틸벤 -2- 글루코시드 등이 있다. The sewage (Pleuropterus multflorus) is a shrub and perennial deciduous vine plant with a stem about 1-3m long and relatively short. It contains 1.8% of oxymethylanthraquinone derivatives such as chrysopanolpa, chrysopanolanthrone, emodine, emodine monomethyl ester, pistion and derivatives thereof, 45% of hemp, 3% of oil, 3.7% of lecithin, and tetrahydroxy. Stilbene-2-glucoside and the like.
강정, 강장, 간과 신을 보하고 피와 정을 보하며 힘줄과 뼈를 튼튼하게 하고, 일반허약자, 혈허증, 허리아픔, 가슴두근거림, 불면증, 신경쇠약, 학질, 당뇨병, 변비, 치질, 연약, 근골산통, 유정, 대량의 자궁 출혈 등에 효과가 있다고 알려져 있다.Gangjeong, tonic, liver and god to show blood and jeong, strengthen tendons and bones, general weakness, blood loss, back pain, heart palpitations, insomnia, nervous breakdown, malaria, diabetes, constipation, hemorrhoids, weakness, It is known to be effective for muscle pain, oil well, and massive uterine bleeding.
상기 은행나무(학명:Ginkgo biloba)는 우리나라 어디서나 볼 수 있는 흔한 나무지만, 사람의 도움 없이는 번식하지 못한다고 한다. 은행나무에는 플라보노이드의 성분으로 강력한 살균 살충 작용을 한다. 또한 은행에는 간놀, 펙틴, 히스티딘, 전분, 단백질, 지방, 당분 등이 많이 들어 있어서 폐결핵 환자나 천식 환자가 오래 먹으면 기침이 없어지고 가래가 적게 나온다. The ginkgo tree (Ginkgo biloba) is a common tree that can be found anywhere in Korea, but it is said that it cannot be reproduced without human help. Ginkgo biloba has a strong bactericidal insecticide as a component of flavonoids. In addition, the bank contains a lot of ganol, pectin, histidine, starch, protein, fat, sugar, etc., pulmonary tuberculosis patients or asthma patients eat for a long time cough and less phlegm.
은행의 특이한 작용 가운데 하나는 레시틴과 비타민 B의 모체가 되는 엘고스테린이라는 성분이 들어 있어서 성욕감퇴 뇌빈혈 신경쇠약 전신피로 등에 효과가 있으며, 뇌혈관을 개선해 주는 효능이 있다. One of the ginkgo's unique actions is that it contains lecithin and elgosterin, the mother of vitamin B. It is effective for systemic fatigue, such as debilitating cerebral anemia, nervous breakdown, and improves cerebrovascular effects.
은행잎은 예부터 민간에서 심장을 돕고 혈액순환을 좋게 하며 폐를 튼튼하게 하고 설사를 멈추게 하는 등의 효능이 있다고 하여 가슴앓이 가래 및 천식 설사 백태 상피증 등을 치료하는 약으로 널리 써 왔다. 은행 잎에 들어 있는 성분은 징코라이드 A B C와 진놀, 플라보노이드 등인데 이는 말초혈관 장애, 노인성 치매 등을 치료 예방하는데 획기적인 효과가 있는 약물로 기대를 모으고 있다고 한다. Ginkgo biloba has been widely used as a medicine to treat heartburn, sputum, and asthma diarrhea and white spot epithelium, because it has the benefits of helping the heart, improving blood circulation, strengthening the lungs, and stopping diarrhea. Ginkgo biloba leaves contain ingredients such as ginkgolide A B C, ginol and flavonoids, which are said to be expected to have significant effects in preventing and preventing peripheral vascular disorders and senile dementia.
상기 연(학명:Nelumbo nucifera)은 연못의 뻘에서 자라는 귀한 약재이자 뛰어난 영양식품으로 모세혈관강화 자양강장 피로회복 고혈압에 효과가 있는 식물이다. 즉 연은 잎 꽃 줄기 꽃대 뿌리 모두가 중하게 쓰이는 약제이며 식품이다. The kite (Nelumbo nucifera) is a precious medicinal plant that grows in the pond of the pond and is an excellent nutritional food that is effective for capillary-enhanced nourishment tonic fatigue recovery hypertension. In other words, lotus is an important food and food used by both leaf flower stem flower stem root.
그 성분으로는 자협(子莢)에 nuciferine, N-nornuciferine, oxoushinsunine와 N-noramepavine이, 뿌리줄기는 전분, 단백질, asparagine, 비타민 C, catechol, d-gallocatechol, neochlorogenic acid, leucocyanidin, leucodelphinidin, peroxydase를 함유하고, 잎에는 roemerine, nuciferine, nornuciferine, armepavine, pronuciferine, N-nornuciferine, D-N-metthylcoclaurine, anonaine, liriodenine, quercctin, isoquercitrin, nelumboside, tartaric acid, malic acid, gluconic acid, acetic acid, succinic acid, 탄닌, 구연산이 함유되어 있다. Its components include nuciferine, N-nornuciferine, oxoushinsunine and N-noramepavine, and root stems contain starch, protein, asparagine, vitamin C, catechol, d-gallocatechol, neochlorogenic acid, leucocyanidin, leucodelphinidin, and peroxydase. The leaves contain roemerine, nuciferine, nornuciferine, armepavine, pronuciferine, N-nornuciferine, DN-metthylcoclaurine, anonaine, liriodenine, quercctin, isoquercitrin, nelumboside, tartaric acid, malic acid, gluconic acid, acetic acid, tannin Citric acid is contained.
진정, 강장, 설사, 유정, 가슴두근거림, 불면증, 건위의 효능이 있고, 폐결핵, 축농증, 조루, 백탁, 백대, 이질에 효과가 있다고 알려져 있다.It is known to be effective in calming, tonic, diarrhea, oil well, palpitations, insomnia, and stomach, and is effective in pulmonary tuberculosis, sinusitis, premature ejaculation, white cloud, white band, and dysentery.
상기 인삼(학명:Panax ginseng C.A.Meyer) 은 우리가 잘 아는 최고의 약용 식물로 예로부터 불로장생 익기(益氣) 경신(輕身)의 명약으로 일컬어져 왔으며, 자양 강장 강정에 대표적인 약제라 할 수 있다.The ginseng (Panax ginseng C.A.Meyer) is the best medicinal plant we know well, and has been known as an ointment of bulgogi ripening since ancient times.
현대 과학으로 연구한 결과 알려진 것은, 인삼사포닌의 배당체로서는 파낙사디올과 파낙사트리올 β-시스토스테롤 및 올레아놀산, 고유의 향기 성분인 파나센(panacen), 폴리아세틸렌계 화합물, 함질소 성분, 알칼로이드, 캠페롤 트리폴림 파나세노이드 등의 플라보노이드(flavonoid), 비타민, 미량원소로 망간 구리 바나듐 코발트 비소 게르마늄 인 알루미늄 니켈 등과 아밀라아제 등의 효소(酵素)가 있다. As a result of research by modern science, glycosides of ginseng saponin are known as panaxadiol, panaxtriol β-cystosterol and oleanoic acid, intrinsic fragrance components panacen, polyacetylene compounds, nitrogen-containing components, Flavonoids, such as alkaloids and camphorol tripolim panacenoid, flavonoids, vitamins, and trace elements include manganese copper vanadium cobalt arsenic germanium aluminum nickel and enzymes such as amylase.
인삼은 일반적으로 뿌리(근)을 주로 이용하는데, 뿌리 외에 잎이나 줄기에도 주요 성분이 풍부하지만, 효과적인 이용 방법이 없었다고 할 수 있는데, 본 발명에서와 같이 특수고압 유산발효방법을 이용하면 매우 효과적으로 줄기 잎의 성분을 용출시켜 이용할 수 있다. In general, ginseng is mainly used for the root (root), but there are abundant main components in the leaves and stems, but it can be said that there was no effective use method, using the special high-pressure lactic acid fermentation method as in the present invention very effective stem The component of a leaf can be eluted and used.
상기 석류(학명:Punica granatum)는 석류나무는 석류나무과에 속하는 낙엽성 소교목이다. 다른 이름으로는 안석류, 산석류, 감석류로 부른다. 대장경, 신경에 작용한다. 장을 수렴하고 설사와 출혈을 멈추게 하는 것으로 설사, 이질, 자궁부정출혈, 장출혈, 대하, 유정, 탈항 등에 쓴다. The pomegranate (Punica granatum) is a deciduous microflora belonging to the pomegranate, which belongs to the pomegranate family. In other names, it is called asbite, asphylum and ascitic. Colonoscopy, acting on the nerves. Converging the intestines to stop diarrhea and bleeding, diarrhea, dysentery, uterine bleeding, intestinal bleeding, treat, oil well, prolapse.
동국대학교 식품공학과에서는 석류에는 당질, 아미노산, 미네랄, 비타민, 스테로이외에도 스테로이드 호르몬인 에스트론, 에스트라디올이 다량 함유되어 있다고 밝혔다.According to the Department of Food Science and Technology, Dongguk University, pomegranate contains high amounts of steroid hormones estrone and estradiol in addition to sugars, amino acids, minerals, vitamins and steroids.
또한 신라대학교 식품영양학과 연구진은 석류를 이용한 식물성 에스트로겐의 효과를 실험한 결과 β-estrodiol과 높은 활성을 나타내어 ethylacetate층인 PGMEA층속에 에스트로겐이 함유되어 여성호르몬에 역할을 해주는 연구결과가 발표되었다. In addition, researchers at the Department of Food Science and Nutrition, Silla University, tested the effects of phytoestrogens using pomegranate, and showed a high activity with β-estrodiol, which contained estrogen in the ethylacetate layer, PGMEA.
상기 아마(亞麻-학명:Linum usitatissimum L.)씨는 아마자(亞麻子), 아마인(亞麻仁)이라고도 하며, 아마는 러시아의 카프카스 지방으로부터 중앙아시아 원산으로 유럽에서 오래전부터 재배해 온 한해살이풀로 높이가 60~120센티미터이다. 북위 36도로부터 60도까지의 지대에 널리 퍼져 있다.Linama usitatissimum L. is also known as flax, linseed, and is a perennial plant that has been cultivated in Europe for a long time in Europe from the Caucasus region of Russia. The height is 60 to 120 centimeters. It is widespread in the zone from 36 degrees to 60 degrees north.
씨에는 건성유 48%, 점액 3~9%, 단백질 20%, 탄수화물 12~20%, 배당체 리나마린(파세오루나틴) C10 H17 O6 N(녹는점 142~143℃), 리노시나마린, 리나아제(효소), 스테아린, 유기산, 아미노산이 있다. 기름은 리놀레산(35~45%), 리놀산(25~35%), 올레산(15~20%), 팔미트산과 스테아르산(8~9%)의 글리세리드이다. 씨껍질에는 물분해할 때 리노카페인 C16 H20 O9과 리노시나마린 C16 H20 O8이 생기는 고분자 화합물이 있다.Seeds contain 48% of dry oil, 3-9% of mucus, 20% of protein, 12-20% of carbohydrates, glycoside linamarin (paseolunan) C10 H17 O6 N (melting point 142-143 ° C), linosinamarin, linase ( Enzymes), stearin, organic acids, amino acids. Oil is a glyceride of linoleic acid (35-45%), linoleic acid (25-35%), oleic acid (15-20%), palmitic acid and stearic acid (8-9%). Seeds contain high-molecular compounds that, when hydrolyzed, produce lino-caffeine C16 H20 O9 and linosinmarin C16 H20 O8.
아마씨는 오메가-6보다 오메가-3가 많은 유일한 천연 식품으로써, 아마씨유에 포함된 지방산인오메가-3(알파 리놀렌산)로부터 얻어지는 건강의 이익 때문에 근래에 북미지역에서는 아마씨를 일상생활의 식이요법으로 선호하고 있습니다. Flaxseed is the only natural food with more omega-3s than omega-6. Recently, flaxseed is the preferred diet in North America because of the health benefits of omega-3 (alpha linolenic acid), a fatty acid contained in flaxseed oil. There is.
리나마린은 식물 전체, 특히 어린 식물에 들어 있다. 전초에는 리나마린, 약 20개의 페놀카르복시산(P-쿠마르산, P-옥시벤조일산, 페룰라산, 바닐린산, 시레닌산, 클로로겐산, 네오클로로겐산, 카페일키나산 등)과 14개 이상의 플라보노이드 배당체(아피게닌과 루테올린의 C-배당체, O-C-배당체), 옥시쿠마린(에스쿨레틴과 에스쿨린)이 있다.Linamarin is found in whole plants, especially young ones. Outposts include linamarin, about 20 phenolcarboxylic acids (P-coumaric acid, P-oxybenzoyl acid, ferulic acid, vanillic acid, cyrenic acid, chlorogenic acid, neochlorogenic acid, caffeyl kinanic acid, etc.) and 14 or more flavonoid glycosides ( C-glycosides of apigenin and luteolin, OC-glycosides), and oxycoumarins (esculletin and esculin).
아마씨는 각종 혈관 및 심장 질환 예방, 죄졸증의 예방과 치료, 항암효과, 아토피성 피부염등 피부질환, 두뇌의 성장 발육촉진에 효과가 있으며, 전체 지방산의 57%가 오메가 3지방산으로 구성돼 몸 안의 콜레스테롤을 몸 밖으로 배출,암 예방을 돕는 데 효과적으로 알려져 있다.Flaxseed is effective in preventing various vascular and heart diseases, preventing and treating sinus, anti-cancer effect, skin diseases such as atopic dermatitis, and promoting the growth and development of the brain. 57% of all fatty acids are composed of omega-3 fatty acids. It is known to effectively release cholesterol out of the body and help prevent cancer.
특히 중년기 이후의 골다공증과 갱년기 증상 완화에 좋은 식물성 에스트로겐이라 하는 리그난이 석류보다 2700배나 많게 함유돼 있다고 한다. In particular, lignans, called phytoestrogens, are good for relieving osteoporosis and menopausal symptoms after middle age.
상기 엉겅퀴(학명: Cirsium japonicum var. ussuriense)는 국화과의 다년초로 가시나물, 조방가새라고도 한다. 엉겅퀴에는 타라카스테린 아세테이트, 스티그마스케롤, 알파 또는 베타 아말린 등이 들어 있어 피를 맑게 하며 저혈, 소염작용을 한다.The thistle (cisium: Cirsium japonicum var.ussuriense) is a perennial herb of the Asteraceae, also known as spiny herb, gingiva vulture. Thistle contains taracaster acetate, stigmaskerol, alpha or beta amalin, which clears the blood and acts as a hypoglycemic and anti-inflammatory agent.
엉겅퀴는 정력을 보강하는 것으로 널리 알려져 있다. 독은 없으며 맛은 달고 이뇨, 해독, 소염작용이 있으며 열이 혈액의 정상 순환을 방해하지 않도록 다스린다. 지혈작용이 있어 각종 출혈, 예를 들면 토혈, 코피, 잇몸출혈, 대변출혈, 소변출혈, 자궁출혈 등에 응용된다.Thistle is widely known to enhance vibrancy. It is not poisonous, tastes sweet, diuretic, detoxifying, anti-inflammatory and helps to prevent fever from disrupting the normal circulation of blood. It has a hemostatic effect and is applied to various kinds of bleeding, for example, bleeding, nosebleed, gum bleeding, fecal bleeding, urine bleeding, and uterine bleeding.
이 밖에도 폐렴과 폐농양에 좋고, 혈압을 떨어뜨리는 작용이 있어 고혈압에 응용되며, 속칭 냉증이라 일컬어지는 각종 대하증도 치효할 수 있다. 즉 감기, 백일해, 고혈압, 장염, 신장염, 토혈, 혈뇨, 혈변, 산후에 출혈이 멎지 않는 증세, 대하증, 종기의 치료에 쓰인다. In addition, it is good for pneumonia and lung abscess, it has a function of lowering blood pressure, so it is applied to high blood pressure, and various kinds of sputum called so called cold symptoms can be effective. In other words, colds, whooping cough, high blood pressure, enteritis, nephritis, hemostasis, hematuria, bloody stools, postpartum bleeding does not stop, sputum, boil is used to treat.
상기 꽃매미(Lycorma delictula White)는 중국매미, 주홍날개꽃매미라고도 한다. 원래 매미는 나무의 수액을 빨아먹고 사는 동물로, 옛날부터 약제로 이용되어 왔다. 이 꽃매미는 외래종으로 환경생태계를 파괴하는 교란동물로 지탄을 받고 있지만, 중국의 <본초강목> <황제내경> <신농본초경>의 의학서에 약용 곤충으로 분류되어 혈액순환에 좋고 해독효능이 있다고 알려져 생리불순이나 종기를 치료하는 데 애용되고 있다.The cicada (Lycorma delictula White) is also called Chinese cicada, scarlet wing cicada. Originally, cicada is an animal that sucks sap from trees and has been used as a medicine since ancient times. Although the cicada has been criticized as a disturbing animal that destroys the ecological system as an exotic species, it is classified as a medicinal insect in the medical texts of Chinese Herbal Medicine, Emperor Bore, and New Cornflower Carbide, which is known for its good circulation and detoxification effect. It is used to treat menstrual irregularities and boils.
또한 인솔아이칼로이드 등의 성분이 있어 혈류개선과 발기부전에 효과가 뛰어나다고 한다. In addition, there are ingredients such as insol eyecaloid, which is said to be effective in improving blood flow and erectile dysfunction.
이 꽃매미는 해파리와 함께 환경생태계 파괴 동물이지만 본 발명 건강기능식품에 활용함으로서 국가적인 과제를 해결하고, 쉽게 원재료를 확보하며, 그 효능을 잘 활용하는 일거삼득의 효과를 가져 온다. This cicada is an ecological destructive animal with jellyfish, but by utilizing it in the health functional food of the present invention, it solves the national problem, easily secures the raw materials, and brings the effect of one to three benefits.
상기 해파리는 해양환경생태파괴동물로 우리나라의 연근해에서도 피해가 막심하여 국가적인 과제를 주고 있지만, 수분함량이 매우 높고, 뮤신(mucin)의 콘드로이틴성분이 피부노화방지에 효능이 있고 자양 강장에도 효과가 있다. The jellyfish is a marine environmental ecological destructive animal, causing severe national damage in the coastal waters of Korea. However, the jellyfish has a high water content, and mucin's chondroitin ingredient is effective in preventing skin aging and effective in nourishing tonic. have.
상기 식물이 함유하고 있는 성분을 중탕 등 물리 화학 생리적인 다른 많은 방법으로 추출하여도 완전추출이 아주 어려워, 부작용 없이 그대로 이용하는 방법이 없는 실정이다.Complete extraction is very difficult even if the components contained in the plant are extracted by many other methods such as physicochemical and physiological methods, and there is no method of using them as they are without side effects.
100~150기압의 특수고압유산발효는 약용식물을 10~50나노로 완벽히 용해시켜 배당체의 손상 없이, 식물 특유 성분을 그대로 이용할 수 있게 하며, 흡수를 쉽게 하여 그 효능을 크게 높이는 효과를 얻을 수 있다.
Special high pressure lactic acid fermentation of 100 ~ 150 atmosphere completely dissolves medicinal plants into 10 ~ 50 nanometers, so that the unique ingredients of plants can be used as it is without damaging glycosides. .
식물이 꽃피는 시기인 개화기에 갓 채취된 생물상태(生草)의 삼지구엽초, 야관문, 가시오가피 (가지 잎), 울금, 광나무 (가지 잎), 만삼, 복분자 열매, 하수오, 은행나무 (가지 잎 열매), 연 (잎 꽃대 줄기 뿌리), 인삼 (잎 줄기), 석류열매, 아마씨, 엉겅퀴, 꽃매미를 각각 잘게 분쇄하여 소정 량을 각각 특수고압 발효탱크에 넣고 소정 량의 해파리 추출액과 발효매체인 설탕이나 올리고당 및 유산균을 혼합하여 최적의 온도와 발효기간을 통해 얻어진 각각의 발효액을 최적의 조함으로 혼합하여 본 발명 조성물을 얻는다.Freshly harvested trigeminal vinegar, night gate, prickly pear (branch leaf), turmeric, mineral wood (branch leaf), mandarin, bokbunja fruit, sewage, ginkgo (branch leaf fruit), freshly harvested during flowering period ), Lotus (leaf stalk root), ginseng (leaf stem), pomegranate, flaxseed, thistle, and cicada, each finely crushed, and put a predetermined amount into a special high-pressure fermentation tank and sugar of jellyfish extract and fermentation medium. In addition, the oligosaccharides and lactic acid bacteria are mixed, and each fermentation broth obtained through an optimum temperature and fermentation period is mixed with an optimum coarseness to obtain a composition of the present invention.
상기 원재료 중 식물의 채취는 식물의 영양과 성분이 가장 많이 형성될 때인 개화기에 채취하는 것이 바람직하며, 꽃매미는 여름이 지나고 가을에 채취하여 날개는 버리고 몸통만을 분쇄하여 사용하며, 해파리는 수분함량이 가장 많고 신선한 것을 사용하기 위하여 바다에서 직접 수거된 것을 현장에서 탈수하여 액을 얻는 것이 바람직하다. It is preferable to collect the plant from the raw material during the flowering period when the nutrition and the constituents of the plant are formed the most, the cicada is collected in the fall after summer, and the wings are discarded and only the trunk is crushed, and the jellyfish has moisture content. In order to use the most fresh, it is desirable to obtain the liquid by dewatering it directly from the sea.
석류는 뿌리 줄기 잎 열매 등을 모두 다 사용할 수 있지만, 열매를 주로 사용한다. 또한 아마는 어린줄기와 잎을 분쇄하여 사용하기도 하지만, 씨를 주로 사용한다. Pomegranate can be used for all of the rhizome leaves, but mainly fruit. Flax is also used to crush young stems and leaves, but mainly seeds.
그 외 상기 식물원재료는 뿌리 잎 줄기 열매 가지 등 식물 전체를 채취하여 깨끗이 씻어 이용하는 것, 목질부(나무)는 껍질을 벗겨 이용하는 것이 바람직하다. In addition, the botanical raw material is preferably used to wash the whole plant, such as root leaf stem fruit branch, and to remove the bark wood (wood).
상기 원재료들은 성분이나 활성 성질에 많은 차이가 있고, 발효기간에서도 상당한 차이가 있게 되어, 각각의 특수 고압 발효탱크에서 발효시키는 것이 바람직하다.The raw materials have many differences in ingredients and active properties, and there is a significant difference in fermentation period, and it is preferable to ferment in each special high pressure fermentation tank.
보다 구체적으로는,More specifically,
상기 생초상태의 식물원재료는 잎 줄기 가지 뿌리를 포함한 식물 전체를 개화기에 채취하여 세척한 다음 각각 1~5m/m 로 분쇄한다.The raw plant material of the raw state is collected by washing the whole plant, including the leaf stem branch root, and then crushed to 1 ~ 5m / m each.
이렇게 분쇄된 삼지구엽초, 야관문, 가시오가피, 울금, 광나무, 만삼, 복분자, 하수오, 은행나무, 연, 인삼, 석류, 아마씨, 엉겅퀴, 꽃매미의 분쇄 물 각각50kg을 특수 고압 발효탱크에 각각 넣고, 여기에 설탕이나 올리고당 또는 이들의 혼합물로 된 발효 촉매제15kg 유산균1kg 해파리 추출액100ℓ를 혼합하여 25~50℃의 온도에서 30~90일간 발효시켜 발효액을 얻는다.50 kg each of the trigeminal leaf vinegar, night gate, prickly pear, turmeric, mineral wood, ginseng, bokbunja, sewage, ginkgo, lotus, ginseng, pomegranate, flaxseed, thistle and cicada are put in a special high-pressure fermentation tank. 100 kg of lactic acid bacteria 1kg jellyfish extract 100g fermentation catalyst made of sugar, oligosaccharide or a mixture thereof is mixed and fermented at a temperature of 25-50 ° C. for 30-90 days to obtain a fermentation broth.
밀봉된 상기 특수고압발효탱크의 내부 압력은 100~150기압을 유지하도록 함으로서, 일반적인 발효 방법의 상압이나 발효탱크가 개방된 상태에서의 발효 방법에 비하여 10~50나노로 완벽히 용해시켜 그 모든 성분을 그대로 이용할 수 있게 하며, 흡수를 쉽게 하고 발효시간을 단축시킬 수가 있다.The internal pressure of the sealed special high-pressure fermentation tank is maintained at 100 to 150 atm, thereby completely dissolving all components to 10 to 50 nanometers compared to the normal pressure of a general fermentation method or the fermentation method in an open state of the fermentation tank. It can be used as it is, can be easily absorbed and shorten fermentation time.
상기 원재료에 유산균을 넣어 발효시키는 시간이 30~90일간 소요되는 이유는 발효 장소의 주위환경에 의한 차이도 있지만 원재료의 성질에 따라서 완전히 발효되어 그 성분이 녹아나기까지 시간의 차이가 있다.The reason it takes 30 to 90 days to ferment the lactic acid bacteria into the raw material is different depending on the surrounding environment of the fermentation site, but depending on the nature of the raw material, there is a difference in time until the components are dissolved.
본 발명자의 발효 실험에서는 30일 이상 90일 이내에는 완전히 발효되는 것을 확인하였다.In the fermentation experiment of the present inventors, it was confirmed that the fermentation was completely performed within 30 days or more and 90 days.
상기 원재료의 유산균 발효에 이용되는 발효 촉매제는 올리고당이 적합하나 설탕으로 대체할 수 있으며 올리고당과 설탕을 혼합하여 사용할 수도 있다.The fermentation catalyst used in the lactic acid bacteria fermentation of the raw material is oligosaccharide is suitable, but can be replaced with sugar, oligosaccharides and sugar may be used in combination.
본 발명에 이용되는 유산균은 비피더스나 락토바실러스 균을 이용 하는것이 바람직하다.As the lactic acid bacteria used in the present invention, it is preferable to use bifidus or Lactobacillus bacteria.
유산균 발효가 완료된 상기 원재료는 가는 거름망으로 정밀 여과 과정을 거쳐서 얻어진 발효액을 최적 상태의 비율로 혼합하여 본 발명 조성물을 얻는다. 그 발효액의 혼합비는 하기와 같다.The raw material of the lactic acid bacteria fermentation is completed is mixed with a fermentation broth obtained through a fine filtration process in a fine strainer at an optimum ratio to obtain a composition of the present invention. The mixing ratio of the fermentation broth is as follows.
삼지구엽초 발효액 10~20중량%, 야관문 발효액 20~30중량%, 가시오가피 발효액 5~10중량%, 울금 발효액 5~10중량%, 광나무 발효액 6~12중량%, 만삼 발효액 5~10중량%, 복분자 발효액 6~12중량%, 하수오 발효액 5~10중량%, 은행나무 발효액 5~10중량%, 연 발효액 5~10중량%, 인삼 발효액 6~12중량%, 석류 발효액 3~7중량%, 아마씨 발효액 3~7중량%, 엉겅퀴 발효액 3~7중량%, 꽃매미 발효액 3~7중량%를 혼합한다.10 ~ 20% by weight of fermented liquor of Trifolium vinegar, 20 ~ 30% by weight of fermentation broth, 5 ~ 10% by weight of fermented oak bark, 5 ~ 10% by weight of turmeric fermentation, 6 ~ 12% by weight of fermented oak, 5 ~ 10% by weight of ginseng fermentation Fermentation broth 6-12 wt%, sewage fermentation 5-10 wt%, ginkgo fermentation 5-10 wt%, annual fermentation 5-10 wt%, ginseng fermentation 6-12 wt%, pomegranate fermentation 3-7 wt%, flaxseed fermentation 3-7% by weight, 3-7% by weight thistle fermentation broth, 3-7% by weight calyx fermentation broth.
이렇게 혼합된 본 발명 조성물은 살아있는 발효유산균의 효능을 식물의 특유성분과 함께 그대로 이용하므로 살균이나 멸균 또는 방부처리는 하지 않으며 3~7℃의 온도에서 냉장 보관하는 것이 바람직하다.The mixed composition of the present invention uses the efficacy of live fermentation lactic acid bacteria as it is with the unique components of the plant as it is not sterilized, sterilized or preservative, it is preferable to store at refrigerated at a temperature of 3 ~ 7 ℃.
본 발명 조성물은 소정 량을 기호음료와 같이 음용하는 것이 좋은 방법이나 보관이나 휴대가 간편하도록 앰플 캡슐 정제로도 제조할 수가 있다.The composition of the present invention may be prepared as an ampoule capsule tablet so as to drink a predetermined amount like a beverage of preference and to simplify storage and portability.
상기한 구성 및 작용효과를 가지게 되는 본 발명조성물은 특수고압탱크에서 고압발효과정을 거치므로 원재료의 냄새와 독성은 없어지고 성분은 손실 없이 보존되기에, 일반 기호음료와 같이 먹을 수가 있으며 높은 효과를 기대 할 수가 있는 것이다. Since the composition of the present invention having the above-described composition and working effect is subjected to a high-pressure developing tablet in a special high pressure tank, the smell and toxicity of the raw materials are eliminated and the ingredients are preserved without loss, so that they can be eaten like a general beverage and have a high effect. You can expect it.
본 발명 조성물은 일반 화학 제제나 약제 및 달이는 일반한약제와 달리 장기간 복용하여도 내성이나 습관성 부작용이 없어 지속적인 효과를 가져 오게 되는 것이다.
The composition of the present invention, unlike general chemicals or drugs and decoctions of traditional herbal medicines will have a lasting effect without long-term resistance or habitual side effects.
Claims (6)
Trichophytic vinegar fermentation broth obtained from fermentation with lactic acid bacteria, night gateway fermentation broth, brine fermentation broth, turmeric fermentation broth, mineral wood fermentation broth, mandarin fermentation broth, bokbunja fermentation broth, sewage fermentation broth, ginkgo fermentation broth, lead fermentation broth, ginseng fermentation broth, pomegranate fermentation broth, flaxseed fermentation broth, thistle fermentation broth, flower Lactic acid bacteria fermentation health functional food composition having a sexual function improving effect, characterized in that obtained by mixing the cicada fermentation broth.
Freshly harvested trichophyte vinegar, night gate, thorny ginseng, turmeric, mineral wood, ginseng, bokbunja, sewage, ginkgo biloba, lotus, ginseng, pomegranate, flaxseed, thistle and wings to ferment crushed flower cicada Lactic acid bacteria fermentation health functional food composition having an effect of improving sexual function, characterized in that using only jellyfish extract liquid as a fermentation broth.
10 to 20% by weight of trichophytic vinegar fermentation broth obtained by fermentation with lactic acid bacteria, 20 to 30% by weight of fermentation broth, 5-10% by weight of oak bark fermentation broth, 5-10% by weight of turmeric fermentation broth, 6-12% by weight of fermentation of oak wood 10% by weight, bokbunja fermentation broth 6-12%, sewage fermentation 5-10%, ginkgo fermentation 5-10%, annual fermentation 5-10%, ginseng fermentation 6-12%, pomegranate fermentation 3-7 Lactobacillus fermentation health functional food composition having an effect of improving sexual function, characterized in that obtained by mixing 3% by weight, 3-7% by weight of linseed fermentation broth, 3-7% by weight thistle fermentation broth, 3-7% by weight of flower cicada fermentation broth.
분쇄된 원재료를 각각 준비된 특수고압 발효탱크에 넣고 해파리 추출액, 발효촉매제, 유산균을 첨가 혼합하여 발효 탱크에 넣고 밀봉하는 제2단계와:
고압 발효탱크를 섭씨25~50℃의 온도에서 30~90일간 발효시키는 제3단계와:
발효된 원재료로부터 액상 발효액을 추출하는 제4단계와:
원재료로부터 얻어진 액상 추출물을 혼합하는 제5단계로 이루어지는 것을 특징으로 하는 성기능 개선효과를 갖는 무수유산균발효 건강기능식품의 제조방법.
The first step is to crush each raw material consisting of trilobite leaf, night view gate, prickly pear, turmeric, mineral wood, ginseng, bokbunja, sewage, ginkgo, lotus, ginseng, pomegranate, flaxseed, thistle and cicada.
The second step of putting the pulverized raw materials into each prepared special high pressure fermentation tank and adding and mixing jellyfish extract, fermentation catalyst and lactic acid bacteria into the fermentation tank and sealing:
And the third step of fermenting the high pressure fermentation tank at a temperature of 25-50 ° C. for 30-90 days:
A fourth step of extracting the liquid fermentation broth from the fermented raw materials:
A process for producing anhydrous lactic acid bacteria-fermented health functional food having an effect of improving sexual function, comprising the fifth step of mixing a liquid extract obtained from raw materials.
The method of claim 4, wherein the fermentation catalyst is an oligosaccharide, sugar, or a mixture thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100009876A KR20110090217A (en) | 2010-02-03 | 2010-02-03 | Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100009876A KR20110090217A (en) | 2010-02-03 | 2010-02-03 | Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110090217A true KR20110090217A (en) | 2011-08-10 |
Family
ID=44928041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100009876A KR20110090217A (en) | 2010-02-03 | 2010-02-03 | Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110090217A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101346738B1 (en) * | 2011-12-30 | 2013-12-31 | 정은아 | Flaxseed mixed with turmeric added that the number of health food supplements |
WO2016072713A1 (en) * | 2014-11-03 | 2016-05-12 | (주)퓨젠바이오농업회사법인 | Sexual function improving composition containing as active ingredient exopolysaccharide produced by means of ceriporia lacerata |
WO2019014433A1 (en) * | 2017-07-12 | 2019-01-17 | Brandeis University | Probiotic anhydrous fatty foodstuffs and methods of making same |
-
2010
- 2010-02-03 KR KR1020100009876A patent/KR20110090217A/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101346738B1 (en) * | 2011-12-30 | 2013-12-31 | 정은아 | Flaxseed mixed with turmeric added that the number of health food supplements |
WO2016072713A1 (en) * | 2014-11-03 | 2016-05-12 | (주)퓨젠바이오농업회사법인 | Sexual function improving composition containing as active ingredient exopolysaccharide produced by means of ceriporia lacerata |
CN107001487A (en) * | 2014-11-03 | 2017-08-01 | 福健生物技术有限公司 | Contain the exocellular polysaccharide generated by tear wax pore fungi as active ingredient for improving the composition of sexual function |
US9950022B2 (en) | 2014-11-03 | 2018-04-24 | Fugenbio Co., Ltd. | Sexual function improving composition containing as active ingredient exopolysaccharide produced by means of ceriporia lacerata |
WO2019014433A1 (en) * | 2017-07-12 | 2019-01-17 | Brandeis University | Probiotic anhydrous fatty foodstuffs and methods of making same |
US10532076B2 (en) | 2017-07-12 | 2020-01-14 | Brandeis University | Probiotic anhydrous fatty foodstuffs and methods of making same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100404979B1 (en) | Drink for getting rid of the aftereffects of the night's drink and manufacturing method thereby | |
KR20100042337A (en) | The composition of traditional oriental medicines for reheumatoid arthritis and the method of preparing medicine for it | |
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR101332321B1 (en) | Health food fermented using effective micro-organisms with herbal medicine and manufacturing method thereof | |
KR20110112231A (en) | Fermentation method using medicinal leaf and skin external composition containing fermented extract by the method | |
KR20160087112A (en) | Flower tea and method for manufacturing therof | |
KR101855821B1 (en) | Composition for relieving of menopausal symptoms and improving blood circulation | |
CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
KR101751211B1 (en) | Composition for improving sexual function, Functional food Composition for improving sexual function comprising of the same and Manufacturing method thereof | |
KR20120121468A (en) | anhydrous lactobacillus fermentation health function food composition with sex funstion improvements effects | |
CN102273679A (en) | Preparation method of beverage | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
CN104068177A (en) | Health-care life-lengthening natural plant tea | |
KR100891914B1 (en) | The method of preparing the functional food for diet using extrative extrated from madicin-matrrials of plants | |
KR101961356B1 (en) | Composition of Extract of Cirsium Japonicum and Manufacturing method thereof | |
KR101788253B1 (en) | Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic | |
KR20100077781A (en) | Method for preparing functional powder to improve erectile dysfunction and assistance food comprising the functional powder | |
KR20110090217A (en) | Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method | |
CN102485266A (en) | Formula of five-tree sap oral liquid having effects of enhancing immunity, delaying senescence, maintaining beauty and keeping young | |
KR20110056908A (en) | Composition of mixed herb medicine for leached tea | |
CN104095269B (en) | A kind of preparation of pure natural elder seed fruit drink | |
CN106085879A (en) | One medical material is the comprehensive mycelium of culture medium culturing Ganoderma | |
KR101999675B1 (en) | Herbal composition for the prevention and treatment of coronary heart disease | |
KR101404309B1 (en) | The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck | |
CN108208267A (en) | A kind of lowering blood pressure and blood fat, hypoglycemic and the moulding effect of weight-reducing bag bubble ferment health preserving tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |